BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saravanakumar K, Hu X, Ali DM, Wang MH. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy. Curr Pharm Des 2019;25:2609-25. [PMID: 31603055 DOI: 10.2174/1381612825666190709221141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Nazli A, He DL, Liao D, Zafar Irshad Khan M, Huang C, He Y. Strategies and Progresses for Enhancing Targeted Antibiotic Delivery. Adv Drug Deliv Rev 2022;:114502. [PMID: 35998828 DOI: 10.1016/j.addr.2022.114502] [Reference Citation Analysis]
2 Saravanakumar K, Sathiyaseelan A, Priya VV, Wang M. PEGylated palladium doped ceria oxide nanoparticles (Pd-dop-CeO2-PEG NPs) for inhibition of bacterial pathogens and human lung cancer cell proliferation. Journal of Drug Delivery Science and Technology 2022;72:103367. [DOI: 10.1016/j.jddst.2022.103367] [Reference Citation Analysis]
3 Yang X, Duan J, Wu L. Research advances in NQO1-responsive prodrugs and nanocarriers for cancer treatment. Future Med Chem 2022. [PMID: 35102756 DOI: 10.4155/fmc-2021-0289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ji W, Li Y, Peng H, Zhao R, Zhang X. Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases. Adv Drug Deliv Rev 2022;180:114029. [PMID: 34752841 DOI: 10.1016/j.addr.2021.114029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang G, Yang Y, Yi D, Yuan L, Yin PH, Ke X, Jun-Jie W, Tao MF. Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer in vitro and in vivo. J Liposome Res 2021;:1-15. [PMID: 34895013 DOI: 10.1080/08982104.2021.1999974] [Reference Citation Analysis]
6 Józefczak A, Kaczmarek K, Bielas R. Magnetic mediators for ultrasound theranostics. Theranostics 2021;11:10091-113. [PMID: 34815806 DOI: 10.7150/thno.62218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jain NK, Chathoth BM, Bhaskar VS, Meena H, Prasad R, Srivastava R. Nanoengineered photoactive theranostic agents for cancer. Nanophotonics 2021;10:2973-97. [DOI: 10.1515/nanoph-2021-0205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Saravanakumar K, Mariadoss AVA, Sathiyaseelan A, Venkatachalam K, Hu X, Wang M. pH-sensitive release of fungal metabolites from chitosan nanoparticles for effective cytotoxicity in prostate cancer (PC3) cells. Process Biochemistry 2021;102:165-72. [DOI: 10.1016/j.procbio.2020.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Douloudi M, Nikoli E, Katsika T, Vardavoulias M, Arkas M. Dendritic Polymers as Promising Additives for the Manufacturing of Hybrid Organoceramic Nanocomposites with Ameliorated Properties Suitable for an Extensive Diversity of Applications. Nanomaterials (Basel) 2020;11:E19. [PMID: 33374206 DOI: 10.3390/nano11010019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chen L, Chen G, Yang Z, Wang H, Liu N, Liu Y, Fang K, Song Y, Guan X. Enhanced cancer treatment by an acid-sensitive cytotoxic peptide-doxorubicin conjugate. Journal of Drug Delivery Science and Technology 2020;60:102048. [DOI: 10.1016/j.jddst.2020.102048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Skwarecki AS, Nowak MG, Milewska MJ. Synthetic strategies in construction of organic low molecular-weight carrier-drug conjugates. Bioorg Chem 2020;104:104311. [PMID: 33142423 DOI: 10.1016/j.bioorg.2020.104311] [Reference Citation Analysis]
12 Hussain A, Hasan A, Babadaei MMN, Bloukh SH, Edis Z, Rasti B, Sharifi M, Falahati M. Application of gelatin nanoconjugates as potential internal stimuli-responsive platforms for cancer drug delivery. Journal of Molecular Liquids 2020;318:114053. [DOI: 10.1016/j.molliq.2020.114053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
13 Devnarain N, Osman N, Fasiku VO, Makhathini S, Salih M, Ibrahim UH, Govender T. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1664. [PMID: 32808486 DOI: 10.1002/wnan.1664] [Cited by in Crossref: 7] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
14 Skwarecki AS, Nowak MG, Milewska MJ. Synthetic strategies in construction of organic macromolecular carrier-drug conjugates. Org Biomol Chem 2020;18:5764-83. [PMID: 32677650 DOI: 10.1039/d0ob01101k] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Falanga A, Lombardi L, Galdiero E, Genio VD, Galdiero S. The world of cell penetrating: the future of medical applications. Future Medicinal Chemistry 2020;12:1431-46. [DOI: 10.4155/fmc-2020-0140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
16 Sabra S, Agwa MM. Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications. Int J Biol Macromol 2020;164:1046-60. [PMID: 32707283 DOI: 10.1016/j.ijbiomac.2020.07.167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Argenziano M, Foglietta F, Canaparo R, Spagnolo R, Della Pepa C, Caldera F, Trotta F, Serpe L, Cavalli R. Biological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies. Molecules 2020;25:E2775. [PMID: 32560204 DOI: 10.3390/molecules25122775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li F, Fu X, Huo Q, Chen W. Research Progress on the Nano-Delivery Systems of Antitumor Drugs. Nano LIFE 2020;10:2040006. [DOI: 10.1142/s1793984420400061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Selvaraj G, Kaliamurthi S, Wei DQ. Emerging Trends on Nanoparticles and Nano-materials in Biomedical Applications -II. Curr Pharm Des 2019;25:2607-8. [PMID: 31603054 DOI: 10.2174/138161282524190916090945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]